Oliver's mTOR Atlas Evidence Platform
Reading level
Mode

Frauke Neff

First author of the study that separated what rapamycin does to lifespan from what it does to ageing itself

Institute of Pathology and German Mouse Clinic, Institute of Experimental Genetics, Helmholtz Zentrum München, German Research Center for Environmental Health (affiliations as given on NEF2013 and EIS2016)

NEF2013 is one of the more uncomfortable papers in this corpus, and one of the more useful. Rapamycin does extend murine lifespan — that part replicated. But when the same mice were put through a broad phenotyping battery covering many age-sensitive traits, most of them were not rejuvenated. Some of what looked like an anti-ageing effect was better explained as a direct pharmacological effect that happens to be beneficial.

The result is a boundary condition the Atlas keeps in view whenever the lifespan literature is quoted: living longer and ageing more slowly are separate claims that need separate evidence, and a single survival curve does not settle the second one.

She also appears in EIS2016 through the German Mouse Clinic's phenotyping of the spermidine-fed animals — the same discipline applied to a different intervention.

Milestones in the Atlas

YearEvidenceStudy
2013 A Rapamycin extends murine lifespan but has limited effects on aging NEF2013 First author: rapamycin extended lifespan in mice while leaving most age-sensitive phenotypes unchanged, separating lifespan from ageing.
2016 A Cardioprotection and lifespan extension by the natural polyamine spermidine EIS2016 Co-author: contributed to the German Mouse Clinic phenotyping of spermidine-treated mice.

Co-authors in the Atlas

People with a profile here who share at least one study with Frauke Neff.

Every researcher with a profile →

← All researchers